Provention Bio, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Provention Bio, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q3 2021 to Q4 2022.
  • Provention Bio, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending December 31, 2022 was $10.8M.
  • Provention Bio, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending December 31, 2022 was $12.9M.
  • Provention Bio, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $12.9M, a 824% increase from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $12.9M $10.8M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 $756K +$78K +11.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $746K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $580K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q3 2021 $678K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.